Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$317,295,895
+$5,288,280 QoQ
Shares Held
1,249,344
-2.1% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#149
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $1,480,387,003 across 17 Drug Manufacturers - General names. JNJ ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
344,848 | $413,621,071 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,249,344 | $317,295,895 | |
| 3 | ABBV |
AbbVie Inc.
|
975,105 | $245,375,422 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,149,713 | $147,738,120 | |
| 5 | AMGN |
Amgen Inc
|
309,478 | $112,068,173 | |
| 6 | PFE |
Pfizer Inc
|
3,277,599 | $78,924,583 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
975,574 | $56,212,573 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
246,685 | $31,166,182 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $317,295,895 | 1,249,344 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $312,007,615 | 1,276,418 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $278,181,362 | 1,344,196 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $270,038,456 | 1,456,361 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $244,360,590 | 1,599,742 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $280,441,078 | 1,691,034 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $242,638,229 | 1,677,764 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $279,599,849 | 1,725,286 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $259,110,694 | 1,772,788 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $282,284,360 | 1,784,464 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $278,397,826 | 1,776,176 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $280,007,661 | 1,797,802 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $309,003,825 | 1,866,867 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $279,157,015 | 1,801,013 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $312,526,706 | 1,769,186 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $284,739,583 | 1,743,019 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $309,409,515 | 1,743,054 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $303,793,310 | 1,714,119 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $297,070,068 | 1,736,541 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $276,613,324 | 1,712,776 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $264,234,723 | 1,603,950 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $258,833,335 | 1,574,891 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $246,707,471 | 1,567,591 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $233,781,202 | 1,570,266 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $216,920,931 | 1,542,494 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $189,868,372 | 1,447,940 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||